Cerebral Edema in Diabetic Ketoacidosis
Learning Objectives
Identify clinical, laboratory, and physiologic risk factors associated with the development of cerebral edema in patients presenting with diabetic ketoacidosis.
Explain the pathophysiologic relationship between hyperglycemia, serum sodium changes, and cerebral edema risk during the treatment of diabetic ketoacidosis.
Apply corrected serum sodium calculations and serial neurologic assessments to detect early signs of cerebral edema during DKA management.
Analyze evolving neurologic findings and biochemical trends to distinguish cerebral edema from expected changes during DKA treatment.
Evaluate therapeutic responses and escalation strategies for suspected cerebral edema in diabetic ketoacidosis based on clinical presentation and patient response.
Author(s)
Michael Agus, MD
Division Chief | Division of Medical Critical Care | Endowed Chair in Critical Care | Medical Director | Medical Intensive Care Unit | Intermediate Care Program | Co-Medical Director | Biocontainment Unit | Professor of Pediatrics | Harvard Medical School
Traci Wolbrink, MD, MPH
Co-Director, OPENPediatrics; Co-Director, Center for Educational Excellence and Innovation; Program Director, Pediatric Critical Care Medicine Fellowship; Senior Associate in Critical Care Medicine | Boston Children’s Hospital
Associate Professor of Anaesthesia | Harvard Medical School
Citation
Agus M, Wolbrink TA. Cerebral Edema in Diabetic Ketoacidosis. 6/2014. Online video. OPENPediatrics. https://learn.openpediatrics.org/learn/course/internal/view/elearning/3027/cerebral-edema-in-diabetic-ketoacidosis